CBA commonwealth bank of australia.

2.81%

$185.36

Yes agreed. I am thinking that they want to manage the narrative...

First 12 Last

Share
Profile

Follow
Eey Ore

357 Posts.

86

09/08/23

09:57

Post #: 69238510
Share

Originally posted by neoteric: ↑

Management clearly could have presented the accounts in such a way to drive NPAT growth above the 10% reported in 1H23. However, by their own admission, they are maintaining a '$2 billion buffer in provisions relative to losses expected'. A very conservative position, and one that may well understate current profit growth of 5% considerably. Yes, the share price may suffer in the short term as a result, but the bank is focusing very much on next year's financials and beyond.

Loan impairment expenses rose by over $1.4 billion in FY23! I think the fact that the board decided the final dividend can be increased by 30 cents (14%) gives the best indication on how the business is currently performing. This is not the type of board that is likely to hike the dividend one year only to cut it the next year.

Expand

Yes agreed. I am thinking that they want to manage the narrative on how the bank is doing during these hard and about to come harder times for the average punter and customer. Great result.

CBA Price at posting: $102.21 Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

'Not possible' to port renewable gas: ACCC takes AGN to court

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

First 12 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $185.36		Change -5.350(2.81%)		Mkt cap ! $310.1B

Open	High	Low	Value	Volume
$190.50	$191.06	$185.36	$367.6M	1.971M

Buyers (Bids)

No.	Vol.	Price($)
6	4521	$185.36

Sellers (Offers)

Price($)	Vol.	No.
$185.88	70	1

View Market Depth

No.	Vol.	Price($)
3	29	185.360
1	1876	185.330
1	2151	185.230
1	2070	185.140
1	2166	185.050

Price($)	Vol.	No.
185.880	70	1
186.090	50	1
186.510	122	1
186.680	1510	1
186.820	100	1

Last trade - 16.11pm 27/06/2025 (20 minute delay)

CBA (ASX) Chart

Yes agreed. I am thinking that they want to manage the narrative...

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

'Not possible' to port renewable gas: ACCC takes AGN to court

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Yes agreed. I am thinking that they want to manage the narrative...

Top Stories

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

'Not possible' to port renewable gas: ACCC takes AGN to court

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News